Contents and Formulations of Platelet-Rich Plasma

被引:117
作者
Wasterlain, Amy S. [1 ]
Braun, Hillary J. [1 ]
Dragoo, Jason L. [1 ]
机构
[1] Stanford Univ, Dept Orthopaed Surg, Palo Alto, CA 94304 USA
关键词
platelet-rich plasma; contents; mechanism; composition; formulation;
D O I
10.1053/j.oto.2011.11.001
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Multiple studies have demonstrated a role for platelet-rich plasma (PRP) in accelerating and facilitating improved response to injury. The cellular response to injury progresses through 4 general stages: hemostasis, inflammation, proliferation, and finally remodeling. Each phase is characterized by enhanced cellular or molecular activity, all of which involve platelets. Blood plasma and platelets are responsible for hemostasis, whereas leukocytes and activated platelets mediate inflammation, and growth factors derived from platelet alpha-granules influence tissue regeneration. Specifically, the leukocyte content of PRP is thought to influence the inflammatory phase, whereas angiogenic and mitogenic growth factor concentrations are believed to aid tissue regeneration. Both the precise composition of PRP and its formulation affect the cellular environment in which it is placed and determine its overall effect on tissue repair. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 68 条
[1]   Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities [J].
Anitua, E ;
Sanchez, M ;
Nurden, AT ;
Zalduendo, M ;
de la Fuente, M ;
Orive, G ;
Azofra, J ;
Andia, I .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 77A (02) :285-293
[2]   Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture [J].
Anitua, E ;
Andía, I ;
Sanchez, M ;
Azofra, J ;
Zalduendo, MD ;
de la Fuente, M ;
Nurden, P ;
Nurden, AT .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (02) :281-286
[3]   Autologous platelets as a source of proteins for healing and tissue regeneration [J].
Anitua, E ;
Andia, I ;
Ardanza, B ;
Nurden, P ;
Nurden, AT .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (01) :4-15
[4]  
Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
[5]   Fibroblastic response to treatment with different preparations rich in growth factors [J].
Anitua, E. ;
Sanchez, M. ;
Zalduendo, M. M. ;
de la Fuente, M. ;
Prado, R. ;
Orive, G. ;
Andia, I. .
CELL PROLIFERATION, 2009, 42 (02) :162-170
[6]  
Anitua E, J CONTROL RELEASE
[7]  
Araki J, TISSUE ENG C
[8]   Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopaedic applications? [J].
Banfi, G. ;
Corsi, M. M. ;
Volpi, P. .
BRITISH JOURNAL OF SPORTS MEDICINE, 2006, 40 (10) :816-816
[9]   Thrombin and platelet activation [J].
Brass, LF .
CHEST, 2003, 124 (03) :18S-25S
[10]   Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems [J].
Castillo, Tiffany N. ;
Pouliot, Michael A. ;
Kim, Hyeon Joo ;
Dragoo, Jason L. .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2011, 39 (02) :266-271